Identification of Novel Components of Target-of-Rapamycin Signaling Pathway by Network-Based Multi-Omics Integrative Analysis.
biomarkers
caffeine
drug targets
multiomics
network-based analysis
target of rapamycin (TOR) signaling
Journal
Omics : a journal of integrative biology
ISSN: 1557-8100
Titre abrégé: OMICS
Pays: United States
ID NLM: 101131135
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
pubmed:
16
4
2019
medline:
14
4
2020
entrez:
16
4
2019
Statut:
ppublish
Résumé
Target of rapamycin (TOR) is a major signaling pathway and regulator of cell growth. TOR serves as a hub of many signaling routes, and is implicated in the pathophysiology of numerous human diseases, including cancer, diabetes, and neurodegeneration. Therefore, elucidation of unknown components of TOR signaling that could serve as potential biomarkers and drug targets has a great clinical importance. In this study, our aim is to integrate transcriptomics, interactomics, and regulomics data in
Identifiants
pubmed: 30985253
doi: 10.1089/omi.2019.0021
doi:
Substances chimiques
Saccharomyces cerevisiae Proteins
0
Mechanistic Target of Rapamycin Complex 1
EC 2.7.11.1
Mechanistic Target of Rapamycin Complex 2
EC 2.7.11.1
TOR Serine-Threonine Kinases
EC 2.7.11.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM